vs
Side-by-side financial comparison of Amarin Corp plc (AMRN) and RADWARE LTD (RDWR). Click either name above to swap in a different company.
RADWARE LTD is the larger business by last-quarter revenue ($75.3M vs $45.1M, roughly 1.7× Amarin Corp plc). RADWARE LTD runs the higher net margin — 7.5% vs -23.3%, a 30.8% gap on every dollar of revenue. Over the past eight quarters, RADWARE LTD's revenue compounded faster (7.1% CAGR vs -18.3%).
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.
Radware Ltd. is an American provider of cybersecurity and application delivery products for physical, cloud and software-defined data centers. Radware's corporate headquarters are located in Mahwah, New Jersey. The company also has offices in Europe, Africa and Asia Pacific regions. The company's global headquarters is in Israel. Radware is a member of the Rad Group of companies and its shares are traded on NASDAQ.
AMRN vs RDWR — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $45.1M | $75.3M |
| Net Profit | $-10.5M | $5.7M |
| Gross Margin | — | 80.7% |
| Operating Margin | 35.5% | 4.1% |
| Net Margin | -23.3% | 7.5% |
| Revenue YoY | 7.0% | — |
| Net Profit YoY | 33.0% | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | — | ||
| Q3 25 | $49.7M | $75.3M | ||
| Q2 25 | $72.7M | $74.2M | ||
| Q1 25 | $42.0M | $72.1M | ||
| Q4 24 | $62.3M | — | ||
| Q3 24 | $42.3M | $69.5M | ||
| Q2 24 | $67.5M | $67.3M |
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | — | ||
| Q3 25 | $-7.7M | $5.7M | ||
| Q2 25 | $-14.1M | $4.2M | ||
| Q1 25 | $-15.7M | $4.3M | ||
| Q4 24 | $-48.6M | — | ||
| Q3 24 | $-25.1M | $3.1M | ||
| Q2 24 | $1.5M | $1.7M |
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | 80.7% | ||
| Q2 25 | 69.2% | 80.7% | ||
| Q1 25 | 59.8% | 80.6% | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | 80.7% | ||
| Q2 24 | 63.4% | 80.6% |
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | — | ||
| Q3 25 | -22.4% | 4.1% | ||
| Q2 25 | -22.0% | 3.8% | ||
| Q1 25 | -39.9% | 2.2% | ||
| Q4 24 | -84.3% | — | ||
| Q3 24 | -59.5% | -0.0% | ||
| Q2 24 | -0.8% | -1.8% |
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | — | ||
| Q3 25 | -15.6% | 7.5% | ||
| Q2 25 | -19.4% | 5.7% | ||
| Q1 25 | -37.4% | 6.0% | ||
| Q4 24 | -78.0% | — | ||
| Q3 24 | -59.4% | 4.5% | ||
| Q2 24 | 2.3% | 2.5% |
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | — | ||
| Q3 25 | $-0.02 | — | ||
| Q2 25 | $-0.03 | — | ||
| Q1 25 | $-0.04 | — | ||
| Q4 24 | $-0.12 | — | ||
| Q3 24 | $-0.06 | — | ||
| Q2 24 | $0.00 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $307.8M | $98.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $357.1M |
| Total Assets | $645.8M | $618.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | — | ||
| Q3 25 | $286.6M | $98.7M | ||
| Q2 25 | $298.7M | $98.7M | ||
| Q1 25 | $281.8M | $98.7M | ||
| Q4 24 | $294.2M | — | ||
| Q3 24 | $305.7M | $70.5M | ||
| Q2 24 | $306.7M | $70.5M |
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | — | ||
| Q3 25 | $458.9M | $357.1M | ||
| Q2 25 | $464.9M | $357.1M | ||
| Q1 25 | $473.7M | $357.1M | ||
| Q4 24 | $486.2M | — | ||
| Q3 24 | $531.4M | $323.3M | ||
| Q2 24 | $551.9M | $323.3M |
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | — | ||
| Q3 25 | $659.8M | $618.7M | ||
| Q2 25 | $670.1M | $618.7M | ||
| Q1 25 | $655.7M | $618.7M | ||
| Q4 24 | $685.3M | — | ||
| Q3 24 | $750.6M | $571.9M | ||
| Q2 24 | $799.9M | $571.9M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
RDWR
Segment breakdown not available.
